CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
得意分野
Suggested News & Insights
Who Started It? Delaware Court of Chancery to Address Whether Contacting DOJ Is ‘Initiating’ a Proceeding in Advancement CaseMay 5, 2026Securities Litigation Against Life Sciences Companies: 2025May 1, 2026Sidley Represents OppFi In Its Acquisition of BNCC and BNC National BankApril 29, 2026Bad Investments, Not Bad Faith: Caremark Claims Have LimitsApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026FactSet Ranks Sidley No. 1 for Company Defense in Q1 2026April 15, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory